These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20476705)

  • 1. [Utilization of antineoplastic agents in Sweden and Europe].
    Wilking N; Jönsson B; Björn W
    Lakartidningen; 2010 Apr 21-27; 107(16):1075-80. PubMed ID: 20476705
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question.
    Cohen J; Looney W
    J Natl Cancer Inst; 2010 Aug; 102(15):1207; author reply 1207-10. PubMed ID: 20651322
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmaceuticals can be cost-effective in the long run].
    Jönsson B; Wilking N
    Lakartidningen; 2010 Apr 21-27; 107(16):1081-5. PubMed ID: 20476706
    [No Abstract]   [Full Text] [Related]  

  • 4. Genentech caps cost of cancer drug for some patients.
    Pollack A
    N Y Times Web; 2006 Oct; ():C2. PubMed ID: 17061339
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Medical treatment of cancer in the elderly].
    Bangerter M; Heinrich B; Brudler O
    MMW Fortschr Med; 2004 Sep; 146(40):30-2. PubMed ID: 15529665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomics, quality of life, and combination modalities in non-small cell lung cancer: a panel discussion (Part 2).
    Crawford J; Duch DS; Gralla RJ; Hillner BE; Hollen PJ; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):53-5. PubMed ID: 8610238
    [No Abstract]   [Full Text] [Related]  

  • 8. Ixabepilone and the narrow path to developing new cytotoxic drugs.
    Gianni L
    J Clin Oncol; 2007 Aug; 25(23):3389-91. PubMed ID: 17606970
    [No Abstract]   [Full Text] [Related]  

  • 9. [Circadian chemoradiotherapy of solid tumors].
    Svinarenko AV; Sukhina EN; Moskalenko IP; Nikiforova NA; Sorochan PP; Nasonova AN
    Vopr Onkol; 2010; 56(2):138-43. PubMed ID: 20552887
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II oncology trials: let's be positive.
    Ratain MJ
    Clin Cancer Res; 2005 Aug; 11(16):5661-2. PubMed ID: 16115898
    [No Abstract]   [Full Text] [Related]  

  • 11. Does reimbursement influence chemotherapy treatment for cancer patients?
    Jacobson M; O'Malley AJ; Earle CC; Pakes J; Gaccione P; Newhouse JP
    Health Aff (Millwood); 2006; 25(2):437-43. PubMed ID: 16522584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamentals and results of cytostatic chemotherapy in some of the most common solid tumors].
    Brugger SA; Huber H
    Acta Med Austriaca; 1999; 26(3):83-8. PubMed ID: 10520375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine for treatment of advanced non-small-cell lung cancer.
    Med Lett Drugs Ther; 1995 Aug; 37(955):72-3. PubMed ID: 7630328
    [No Abstract]   [Full Text] [Related]  

  • 14. Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.
    Garrison LP
    Oncologist; 2010; 15 Suppl 1():49-57. PubMed ID: 20237218
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing clinical recommendations for breast, colorectal, and lung cancer adjuvant treatments using the GRADE system: a study from the Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group.
    De Palma R; Liberati A; Ciccone G; Bandieri E; Belfiglio M; Ceccarelli M; Leoni M; Longo G; Magrini N; Marangolo M; Roila F;
    J Clin Oncol; 2008 Mar; 26(7):1033-9. PubMed ID: 18309939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [[How to finance chemotherapy with new cancer drugs?].
    Livartowski A; Beuzeboc P; Le Vu B; Courbard M; Pierga JY; Extra JM; Scholl S; Pouillart P
    Bull Cancer; 2000 Oct; 87(10):745-54. PubMed ID: 11084538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How much will Herceptin really cost? The money is already there.
    Minhas R
    BMJ; 2006 Dec; 333(7580):1219; discussion 1219-20. PubMed ID: 17158392
    [No Abstract]   [Full Text] [Related]  

  • 18. Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.
    Del Paggio JC; Sullivan R; Schrag D; Hopman WM; Azariah B; Pramesh CS; Tannock IF; Booth CM
    Lancet Oncol; 2017 Jul; 18(7):887-894. PubMed ID: 28583794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UFT: biochemical modulation for 5-fluorouracil (5-FU).
    Taguchi T
    Chin Med J (Engl); 1997 Apr; 110(4):294-6. PubMed ID: 9594232
    [No Abstract]   [Full Text] [Related]  

  • 20. How much will Herceptin really cost? Balancing local and national priorities is not new.
    Dillon A; Littlejohns P
    BMJ; 2006 Dec; 333(7580):1219; discussion 1219-20. PubMed ID: 17158393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.